Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction

BACKGROUND: The majority of lung cancer(LC) patients are diagnosed at advanced stage with a poor prognosis. However, there is still no ideal diagnostic and prognostic prediction model for lung cancer. METHODS: Data of CEA, CYFRA21-1 and NSE test of patients with LC and benign lung diseases (BLDs) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jingmin, Sun, Yan, Wang, Ke, Wang, Zhiyi, Li, Duo, Fan, Meng, Bu, Xiang, Chen, Jun, Wu, Zhiquan, Geng, Hui, Wu, Jiamei, Xu, Ying, Chen, Mingwei, Ren, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214980/
https://www.ncbi.nlm.nih.gov/pubmed/35729538
http://dx.doi.org/10.1186/s12885-022-09728-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214980/
https://www.ncbi.nlm.nih.gov/pubmed/35729538
http://dx.doi.org/10.1186/s12885-022-09728-5

Ejemplares similares